Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Steven I. Max"'
Autor:
James J. Harding, Ignacio Garrido-Laguna, Xiaoying Chen, Cynthia Basu, Afshin Dowlati, Alison Forgie, Andrea T. Hooper, Cris Kamperschroer, Steven I. Max, Allison Moreau, Megan Shannon, Gilbert Y. Wong, David S. Hong
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
P-cadherin is a cell-cell adhesion molecule that is overexpressed in several solid tumors. PF-06671008 is a T-cell–redirecting bispecific antibody that engages both P-cadherin on tumors and CD3ϵ on T cells and induces antitumor activity in preclin
Externí odkaz:
https://doaj.org/article/cbbc152e331a4efbaff13402339432fe
Autor:
James J. Harding, Ignacio Garrido-Laguna, Xiaoying Chen, Cynthia Basu, Afshin Dowlati, Alison Forgie, Andrea T. Hooper, Cris Kamperschroer, Steven I. Max, Allison Moreau, Megan Shannon, Gilbert Y. Wong, David S. Hong
Publikováno v:
Frontiers in immunology. 13
P-cadherin is a cell-cell adhesion molecule that is overexpressed in several solid tumors. PF-06671008 is a T-cell–redirecting bispecific antibody that engages both P-cadherin on tumors and CD3ϵ on T cells and induces antitumor activity in preclin
Publikováno v:
Handbook of Validation in Pharmaceutical Processes ISBN: 9781003163138
Handbook of Validation in Pharmaceutical Processes
Handbook of Validation in Pharmaceutical Processes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::327c368a36727d7f7dfb51c095f7eed5
https://doi.org/10.1201/9781003163138-37
https://doi.org/10.1201/9781003163138-37
Autor:
Michael J. Morris, A. Oliver Sartor, Jeffrey Y.C. Wong, Steven I Max, Hong Xie, Alex Yu, Chaitanya R. Divgi, Daniel Patricia, Anjali Narayan Avadhani, Neeta Pandit-Taskar, Pedro C. Barata, Luke T. Nordquist
Publikováno v:
Journal of Clinical Oncology. 40:TPS5104-TPS5104
TPS5104 Background: Radioligand therapy for metastatic castration resistant prostate cancer (mCRPC) has been shown to prolong survival, delay disease progression, and improve quality of life, raising hopes that these gains will be amplified with even
Autor:
Timothy S. Charlebois, Martin S. Sinacore, Dana Di Nino, Gene W. Lee, Niall Barron, Steven I. Max, Kathleen Kopycinski, Mark Leonard, Karin Anderson, Mark Melville, Padraig Doolan, Martin Clynes, Patrick Gammell, Paula Meleady, Kevin M. McCarthy
Publikováno v:
Cells and Culture ISBN: 9789048134182
We have previously reported on the development and use of a proprietary CHO-specific microarray and proteomics technology platforms to interrogate large and diverse sets of CHO cell samples, which embodied several industrially relevant phenotypes. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc5552215d736cea533e8730a88bb2d8
https://doi.org/10.1007/978-90-481-3419-9_72
https://doi.org/10.1007/978-90-481-3419-9_72
Autor:
Lincoln T. Potter, Helene Hanchett-Valentine, Jing-Sheng Liang, Steven I. Max, Sherry L. Purkerson, Hannah A. Silberberg, William L. Strauss
Publikováno v:
Life sciences. 52(5-6)
The venom of the Eastern green mamba from Africa, Dendroaspis angusticeps, contains a number of toxins which block the binding of 3H-antagonists to genetically-defined m1 and m4 muscarinic acetylcholine receptors. Most of the anti-muscarinic activity
Publikováno v:
Gene. 171:309-310
A clone containing the H 1 histamine receptor (H 1 HR)-encoding gene was isolated from a human genomic DNA library. The 5′-UTR of the H 1 HR gene reported here differs upstream from bp −142 from that reported previously [Fukui et al., Biochem. Bi
Autor:
Harding, James J., Garrido-Laguna, Ignacio, Chen, Xiaoying, Basu, Cynthia, Dowlati, Afshin, Forgie, Alison, Hooper, Andrea T., Kamperschroer, Cris, Max, Steven I., Moreau, Allison, Shannon, Megan, Wong, Gilbert Y., Hong, David S.
Publikováno v:
Frontiers in Immunology; 4/14/2022, Vol. 13, p1-12, 12p
Revised to reflect significant advances in pharmaceutical production and regulatory expectations, Handbook of Validation in Pharmaceutical Processes, Fourth Edition examines and blueprints every step of the validation process needed to remain complia